TABLE 3.
Univariate analysis of factors in anxiety symptoms.
Variable | Participants with anxiety symptoms | Participants without anxiety symptoms | X2 | p‐value |
---|---|---|---|---|
Gender | 0.100 | 0.760 | ||
Male | 52 | 125 | ||
Female | 21 | 47 | ||
Obesity (BMI > 28) | 0.051 | 1.000 | ||
Yes | 7 | 18 | ||
No | 66 | 154 | ||
Pathological type | 14.405 | <0.0001* | ||
Small cell lung cancer (SCLC) | 19 | 13 | ||
Non‐small cell lung cancer (NSCLC) | 54 | 154 | ||
Stage | 11.908 | 0.001* | ||
Stage I–III | 30 | 111 | ||
Stage IV | 38 | 52 | ||
History of malignancy | 23.231 | <0.0001* | ||
Yes | 33 | 28 | ||
No | 40 | 144 | ||
History of diabetes | 5.964 | 0.018* | ||
Yes | 12 | 11 | ||
No | 61 | 161 | ||
History of hypertension | 9.961 | 0.002 | ||
Yes | 23 | 24 | ||
No | 50 | 148 | ||
History of liquor use | 16.177 | <0.0001* | ||
Yes | 27 | 24 | ||
No | 46 | 148 | ||
History of tobacco use | 19.688 | <0.0001* | ||
Yes (including used to smoke and smoking) | 42 | 47 | ||
No | 31 | 125 |